D5.2 Pre-processing tools

Dec 7, 2022 | Deliverables

ProCAncerI aims to develop novel AI models in order to add precision in the management of
prostate cancer patients by providing diagnostic tools able to reduce overdiagnosis and
overtreatment. To this end, a unique dataset from the project’s clinical sites is being assembled
making sure that image diversity and variability is properly addressed, which would enhance
models’ generalizability. That said, most current multicentric studies employ harmonization
methods either in centralized or federated architectures since it is still impossible to control or
predict all sources of variation. It should be stressed that there is currently no gold standard to
harmonize imaging data in a multicentric setting towards an optimal radiomics pipeline. Instead,
there are research trends that have shown promising results based on which the ProCAncerI
consortium has implemented a number of preprocessing functionalities that can be used to
experiment and optimize the ProCAncerI AI modeling tasks (Deep Learning and Radiomics
based).

Highlights

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

Podcast Spotlight: The Future of Trustworthy AI in Healthcare

The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

Dissemination Event of the ProCAncer-I Project in Vienna, Austria

ProCAncer-I organised the 4th Dissemination Event of the project at the ECR 2025 held in Vienna, Austria, February 25-26, 2025. During the congress, ProCAncer-I organised a Dedicated Session on the project on the 26th of February 2025, at 15.00-16.00, with the title...

The brand effect: how different MRI machines trip up AI

The brand effect: how different MRI machines trip up AI

Prostate cancer can vary greatly in how aggressive it is, and knowing this in advance helps doctors decide the best course of treatment. Magnetic resonance imaging (MRI) is often used to detect prostate cancer, but figuring out just how aggressive the cancer is...

Dissemination Event of the ProCAncer-I Project in Vienna

Dissemination Event of the ProCAncer-I Project in Vienna

We are delighted to invite you to our session, “ProCAncer-I: An AI Platform Integrating Multiparametric MRI and AI Models”, at the European Congress of Radiology (ECR) 2025.  Date: 26 February 2025  Time: 15:00 – 16:00  Location: ECR 2025, Vienna, Austria (conference...

Twitter feed is not available at the moment.

Stay in touch!